Weight Loss

Mounjaro, Orlistat, Wegovy and Xenical are all licensed weight loss and weight management medications in the UK but we often get asked - can you take any of them together and is it safe to do so?

Results of Retatrutide show promising outcomes for those wanting to loose weight and control their Type 2 diabetes...

Researchers found taking weight loss jabs was linked to a lower risk of mental health problems, including a 44% decreased risk of worsening depression associated with semaglutide (Ozempic, Rybelsus & Wegovy)

New research shows that weight-loss drugs could treat addiction to alcohol, cigarettes, gambling and drugs. Experts believe the way the GLP-1 and GIP blockbuster weight loss medications work on the brain’s reward pathway can help reduce cravings for many different substances, not just food. Mounjaro, a GLP-1 Receptor Agonist that helps aid weight loss Glucagon-like peptide-1 receptor agonists (GLP-1s), such as Wegovy, and glucose-dependent insulinotropic polypeptide (GIP) li

GLP-1 receptor agonists help reduce hunger and improve blood sugar control, making it easier to lose weight. However, these drugs do not change the underlying behaviours that influence weight. Once the medication is stopped or reduced, old habits can return, increasing the chance of weight regain...

Weight-loss drugs could treat addiction to alcohol, cigarettes and drugs, research shows. Experts believe the way the medicines work on the brain’s reward pathway reduces cravings for many different substances.

Maintaining weight loss can be more challenging than losing the weight itself. Many people find that after reaching their target weight, old habits creep back in, and the scale starts to climb again. The key to lasting weight management lies in a balanced approach that includes changes in diet, gradual increases in exercise, and, when applicable, thoughtful adjustments to medications like Mounjaro or Wegovy. This post explores practical methods to sustain weight loss by integ

Losing weight is a journey filled with challenges and victories. One of the most powerful tools to stay on course is progress tracking. When you can see how far you've come, it fuels motivation and helps you understand what works and what needs adjustment. This clarity supports healthier habits that last beyond quick fixes or fad diets.

GLP-1 medications like Mounjaro and Wegovy have become popular for managing weight and blood sugar levels. While effective, these drugs often come with side effects such as nausea, diarrhea, acid reflux, and sulphur burps. What many people don’t realize is that certain foods and drinks can make these side effects worse. In particular, diets high in saturated fats and sugary beverages like fizzy drinks and alcohol can increase discomfort. Understanding how these dietary choice

Weight loss medications like Mounjaro and Wegovy have become popular tools for managing weight. These GLP-1 receptor agonists help reduce appetite and improve blood sugar control, supporting effective weight management. Yet, one challenge many face during weight loss is muscle loss, which can affect strength, metabolism, and overall health. Understanding how protein and a balanced diet play a role in preserving muscle mass during weight loss is essential for anyone using thes

Weight loss is often seen as a quick fix, a goal to achieve through the latest fad diet or a new supplement. Yet, many people find themselves caught in a cycle of failed diets and temporary results. The truth is that lasting weight loss depends far more on changing your habits and mindset than on any short-term plan. Sustainable lifestyle changes build a foundation for long-term weight management and overall well-being. This post explores how shifting your mindset and devel

The "King Kong" of weight loss medications, Mounjaro (tirzepatide), is a dual GIP and GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus and for weight loss. As with any medication affecting pancreatic function, questions have emerged regarding potential links between Mounjaro and pancreatic cancer. Current evidence from clinical trials and regulatory reviews does not establish a causal relationship between tirzepatide and pancreatic malignancy. L

The US Food and Drug Administration (FDA) has approved a tablet version of the weight-loss drug Wegovy, according to pharmaceutical giant Novo Nordisk. Although Oral Semaglutide is already on the market in the UK as the brand Rybelsus, this is currently licensed for Type 2 Diabetes. However, Rybelsus can be prescribed off-label for weight loss within the UK by a qualified healthcare professional, which is helpful for those who do not like injections or have needle phobia. Thi

Researchers say daily calorie intake may be up to 10 times more influential than physical activity in weight gain.

You may have heard that Rybelsus is changing doses... RIP 3mg, 7mg & 14mg

There are no strict dietary restrictions with Mounjaro, but eating balanced, nutrient-rich meals helps the medication work most effectively. Many people find smaller portions and lighter meals are easier to tolerate, especially early on. Limiting high-fat, spicy, or overly rich foods can also reduce nausea and improve comfort while your body adjusts. Why diet still matters with Mounjaro NICE (TA1026, 2025) and NHS guidance both stress that Mounjaro should be used alongside a

At the moment, there is no generic version of Mounjaro available. The medication is still under patent protection, meaning only Eli Lilly can produce tirzepatide until that period ends. Generic versions may become available in future years, once regulatory timelines and patent conditions allow. Understanding what “generic” means A generic medicine is an equivalent version of a branded drug that becomes available once patent and exclusivity rights expire. It must contain the s

Mounjaro doesn’t “speed up” metabolism in the traditional sense, but it improves how your body processes glucose and stores energy. By enhancing insulin sensitivity and reducing appetite, it helps the body use energy more efficiently. Over time, this balance can lead to gradual fat loss and better overall metabolic health. How Mounjaro supports metabolic function Metabolism is the body’s process of converting food into energy. NICE (TA1026, 2025) explains that tirzepatide — t

Mounjaro was developed by the pharmaceutical company Eli Lilly and first approved for medical use in 2022. It’s based on years of research into dual hormone therapies that target both GIP and GLP-1 pathways. Its effectiveness has since been demonstrated in large international trials, helping establish it as a new generation of treatment for type 2 diabetes and weight management. How Mounjaro began The story of Mounjaro started in the early 2010s, when researchers explored way

Mounjaro is not usually prescribed alongside other weight-loss injections or tablets, as combining treatments that affect similar hormone pathways could increase side effects or complications. Doctors generally recommend using it as a single therapy so its effects can be properly monitored. If you’re already on another weight management medication, your clinician will advise whether it’s best to pause or switch before starting Mounjaro. Why Mounjaro is used alone NICE (TA1026